HomeNewsTrendsCurrent AffairsAsiatic lion dies of COVID-19 in Tamil Nadu zoo; second death in a month

Asiatic lion dies of COVID-19 in Tamil Nadu zoo; second death in a month

Since the detection of the infection among animals, the zoo management has been involved in hectic efforts to prevent its spread among other animals.

June 16, 2021 / 17:56 IST
Representative image (Source: Shutterstock)

Another lion at the Arignar Anna Zoological Park (AAZP) in Vandalur, succumbed to SARS-CoV-2 on Wednesday morning.

Confirming the death of the Asiatic male lion named Pathbanathan, aged 12 years, Deputy Director of AAZP said the lion was housed in the safari area of the park.

"Samples of the said lion had tested positive for SARS- CoV-2 as per the report of National Institute of High Security Animal Diseases (NIHSAD), Bhopal, communicated on June 3. The lion has been under intensive treatment since then," he said in a statement.

This is the second tragedy that struck the zoo which lost a nine-year-old lioness Neela due to Coronavirus on June 3.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Since the detection of the infection among animals, the zoo management has been involved in hectic efforts to prevent its spread among other animals.

On Monday, the zoo authorities said three lions were responding to the treatment very slowly.

However, all endeavours were being made by the team of zoo veterinarians incoordination with the experts of TANUVAS to ensure that they recover, the AAZP had said.

Owing to COVID-19 infection on its premises, the park launched measures to contain the spread by introducing thermal scanning, social distancing, UV irradiation of feed, complete vaccination of zoo staff against Corona.

Animal enclosures were sanitised and the staff was mandated to wear the PPE kit.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Jun 16, 2021 05:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347